BIOMAT Database Logo BIOMAT Database Logo

[Clinical use of fludrocortisone acetate in congenital adrenal hyperplasia. Effect on plasma renin activity and aldosterone (author's transl)]. 1980

E Tokuhiro, and S Suwa, and H Maesaka

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005438 Fludrocortisone A synthetic mineralocorticoid with anti-inflammatory activity. 9-Fluorocortisol,9 alpha Fludrohydrocortisone,9 alpha-Fluoro-17-Hydroxycorticosterone,9 alpha-Fluorohydrocortisone,9-Fluoro-17-Hydroxycortisone,9-Fluorohydrocortisone,Astonin,Astonin Merck,Astonin-H,FCOL,9 Fluoro 17 Hydroxycortisone,9 Fluorocortisol,9 Fluorohydrocortisone,9 alpha Fluoro 17 Hydroxycorticosterone,9 alpha Fluorohydrocortisone,Astonin H,Merck, Astonin
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal

Related Publications

E Tokuhiro, and S Suwa, and H Maesaka
Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
May 1968, Pediatrics,
E Tokuhiro, and S Suwa, and H Maesaka
Renin activity, aldosterone secretion, and congenital adrenal hyperplasia.
May 1968, Pediatrics,
E Tokuhiro, and S Suwa, and H Maesaka
Plasma renin activity in congenital virilizing adrenal hyperplasia.
May 1968, Pediatrics,
E Tokuhiro, and S Suwa, and H Maesaka
[Plasma aldosterone and renin activity in hypopituitarism (author's transl)].
January 1979, Annales d'endocrinologie,
E Tokuhiro, and S Suwa, and H Maesaka
[Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
November 1975, Deutsche medizinische Wochenschrift (1946),
E Tokuhiro, and S Suwa, and H Maesaka
[Aldosterone, cortisol and plasma renin activity in pheochromocytoma (author's transl)].
August 1974, Klinische Wochenschrift,
E Tokuhiro, and S Suwa, and H Maesaka
Plasma renin activity in the management of congenital adrenal hyperplasia.
April 1984, Archives of disease in childhood,
E Tokuhiro, and S Suwa, and H Maesaka
Plasma renin activity and mineralocorticoid replacement therapy in congenital adrenal hyperplasia.
January 1979, Acta paediatrica Academiae Scientiarum Hungaricae,
E Tokuhiro, and S Suwa, and H Maesaka
[Effect of ACTH on plasma renin activity, aldosterone level and deoxycorticosterone level in humans (author's transl)].
February 1977, Nihon Naibunpi Gakkai zasshi,
E Tokuhiro, and S Suwa, and H Maesaka
[Plasma renin activity and aldosterone excretion in healthy normotensive children (author's transl)].
February 1980, Lijecnicki vjesnik,
Copied contents to your clipboard!